A study to compare the effects of Clopidogrel, Ticagrelor or Cangrelor on global thrombotic status in patients with Chronic Artery Disease scheduled to undergo PCI

Trial Profile

A study to compare the effects of Clopidogrel, Ticagrelor or Cangrelor on global thrombotic status in patients with Chronic Artery Disease scheduled to undergo PCI

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jul 2017

At a glance

  • Drugs Cangrelor (Primary) ; Clopidogrel (Primary) ; Ticagrelor (Primary)
  • Indications Coronary artery disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top